MyAverix Finance
NS · Healthcare
Rekvina Laboratories Ltd (526075)
Pharmaceuticals & Biotechnology
Rekvina Laboratories Ltd (526075) is listed on NS in the Healthcare sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $225.70M, P/E ratio is -87.40, net margin is -6.7%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 526075
Rekvina Laboratories Ltd (526075) — FAQ
What is Rekvina Laboratories Ltd's market cap?
Rekvina Laboratories Ltd (526075) has a reported market cap of $225.70M (data as of 2026-07-10).
What is 526075's P/E ratio?
The price-to-earnings (P/E) ratio for Rekvina Laboratories Ltd (526075) is -87.40 (data as of 2026-07-10).
Does Rekvina Laboratories Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Rekvina Laboratories Ltd (526075). Check the MyAverix Finance app for the latest dividend data.
What sector is Rekvina Laboratories Ltd in?
Rekvina Laboratories Ltd (526075) is classified in the Healthcare sector (Pharmaceuticals & Biotechnology industry).
What exchange is 526075 listed on?
526075 is listed on NS.
What is Rekvina Laboratories Ltd's net margin?
Rekvina Laboratories Ltd (526075) reports a net margin of -6.7% (data as of 2026-07-10).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.